铭普光磁：10月24日召开董事会会议

Group 1 - The core point of the article is that Mingpu Optoelectronics (SZ 002902) held its 14th meeting of the 5th Board of Directors on October 24, 2025, to review the proposal for the Q3 2025 report [1] - For the first half of 2025, the revenue composition of Mingpu Optoelectronics is entirely from the manufacturing of computers, communications, and other electronic devices, accounting for 100.0% [1] - As of the report date, the market capitalization of Mingpu Optoelectronics is 5.3 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have generated $80 billion in overseas licensing deals this year, indicating a strong performance in the biopharmaceutical sector [1] - A dialogue with Lu Gang, a partner at Chuangdong Investment, highlights the contrast between the hot secondary market for biopharmaceuticals and the cooling fundraising environment in the primary market [1]